Literature DB >> 12047608

Effects of donepezil (Aricept) on the rapid eye movement sleep of normal subjects.

Takashi Kanbayashi1, Tomonari Sugiyama, Rika Aizawa, Yasushi Saito, Yuriko Ogawa, Tsuyoshi Kitajima, Yoshihiko Kaneko, Masahito Abe, Tetsuo Shimizu.   

Abstract

Donepezil (Aricept) is a therapeutic drug for the treatment of Alzheimer's disease (AD). However, there have been only two reports describing the effects of donepezil on sleep as assessed by nocturnal polysomnography (PSG). With this in mind, the effects of donepezil on the sleep of healthy subjects was evaluated using PSG. The results indicated that the percentage of rapid eye movement sleep to total sleep time was increased significantly by a single dose of 5 mg of donepezil when given to healthy subjects immediately before retiring to bed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12047608     DOI: 10.1046/j.1440-1819.2002.01008.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  6 in total

1.  Altered sigma-1 receptor expression in two animal models of cognitive impairment.

Authors:  Nisha K Ramakrishnan; Krisztina Marosi; Csaba J Nyakas; Chantal Kwizera; Philip H Elsinga; Kiichi Ishiwata; Paul G M Luiten; Rudi A J O Dierckx; Aren van Waarde
Journal:  Mol Imaging Biol       Date:  2015-04       Impact factor: 3.488

2.  An open label trial of donepezil for enhancement of rapid eye movement sleep in young children with autism spectrum disorders.

Authors:  Ashura Williams Buckley; Kenneth Sassower; Alcibiades J Rodriguez; Kaitlin Jennison; Katherine Wingert; Jack Buckley; Audrey Thurm; Susumu Sato; Susan Swedo
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-08       Impact factor: 2.576

3.  [Nightmares in patients with Alzheimer's disease caused by donepezil. Therapeutic effect depends on the time of intake].

Authors:  M Singer; B Romero; E Koenig; H Förstl; H Brunner
Journal:  Nervenarzt       Date:  2005-09       Impact factor: 1.214

4.  Recommended protocols for the Multiple Sleep Latency Test and Maintenance of Wakefulness Test in adults: guidance from the American Academy of Sleep Medicine.

Authors:  Lois E Krahn; Donna L Arand; Alon Y Avidan; David G Davila; William A DeBassio; Chad M Ruoff; Christopher G Harrod
Journal:  J Clin Sleep Med       Date:  2021-12-01       Impact factor: 4.324

5.  The Effect of Rivastigmine Transdermal Patch on Sleep Apnea in Patients with Probable Alzheimer's Disease.

Authors:  Hyeyun Kim; Hyun Jeong Han
Journal:  Dement Neurocogn Disord       Date:  2016-12-31

Review 6.  Circadian Rhythm and Alzheimer's Disease.

Authors:  Jan Homolak; Monika Mudrovčić; Barbara Vukić; Karlo Toljan
Journal:  Med Sci (Basel)       Date:  2018-06-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.